No Data
No Data
Truist Securities Maintains Buy on Elevance Health, Raises Price Target to $510
Express News | Elevance Health : Truist Securities Raises Target Price to $510 From $480
Elevance Health, Inc.'s (NYSE:ELV) Stock Is Going Strong: Is the Market Following Fundamentals?
Barclays Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $512
Barclays Sticks to Its Buy Rating for Elevance Health (ELV)
Mizuho Securities Maintains Elevance Health(ELV.US) With Buy Rating, Announces Target Price $505